Market Overview:
The global arsenic trioxide drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer, rising demand for novel therapies, and growing investments by pharmaceutical companies in R&D activities. By type, the 1mg/ml segment is expected to account for a larger share of the global arsenic trioxide drugs market than the 2mg/ml segment during the forecast period. By application, hospitals are expected to account for a larger share of the global arsenic trioxide drugs market than pharmacies during the forecast period. Geographically, North America is expected to dominate the global arsenic trioxide drugs market duringthe forecast period followed by Europe and Asia Pacific.
Product Definition:
Arsenic trioxide is a medication used to treat acute promyelocytic leukemia (APL), a type of cancer of the blood and bone marrow. It is given by injection into a vein.
1mg/ml:
1mg/ml is a concentration used in the preparation of various medicines. It's also used as an intermediate for the synthesis of pesticides and other agrochemicals. The growth factor in arsenic trioxide drugs market is driven by factors such as rising prevalence of cancer, increasing demand for cost-effective medicines, and growing geriatric population base across the globe.
2mg/ml:
2mg/ml is the concentration of Arsenic Trioxide in water. It is used as an ingredient for manufacturing various products including medicinal drugs, which are used to treat cancer and other diseases. 2mg/ml can also be known as pentaerythritol, a chemical or sometimes called trioxane.
It has three hydroxyl groups (3OH) and one carbon chain (C5).
Application Insights:
The global market is segmented by application into hospital, pharmacy and others. The hospital segment dominated the market in 2017 owing to increasing usage of arsenical trioxide drugs for various conditions such as diabetes, cancer and cardiovascular diseases. Arsenic trioxide drugs are used for the treatment of acute as well as chronic forms of these aforementioned diseases due to its anti-metabolic activity.
The use of arsine oxide derivatives in the form of a drug with antidiabetic properties has been known since ancient times owing to their ability to lower blood sugar levels. However, due to stringent regulations related towards food additives coupled with growing awareness regarding side effects associated with these compounds; manufacturers have started manufacturing generic medicines containing less than 2% arsenical trioxide content which can be used safely during pregnancy without any specific warnings or precautions being advised by health authorities.
Pharmaceutical companies including Pfizer Inc.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. The presence of a large number of manufacturers coupled with cheap labor costs has led to high production volumes in this region. Furthermore, increasing demand forarsenictrioxide drugs from countries such as China, India and Japan owing to rising healthcare expenditure is anticipated to drive growth over the forecast period.
The Asia Pacific regional market was followed by North America which accounted for 24% share of global revenue in 2017 due to growing product consumption coupled with favorable reimbursement scenario within U.S., Canada & Mexico region especially pertaining 2mg/ml formulation used for treating acute arsenic poisoning cases at hospitals & pharmacies settings.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for arsenic trioxide drugs market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths due to cancer worldwide. This number is expected to increase by about 70% over the next two decades, accounting for 21.7 million new cases and 13 million deaths in 2030. Arsenic trioxide is used as a treatment for various types of cancers such as acute promyelocytic leukemia (APL), chronic myeloid leukemia (CML), and other solid tumors including lung, ovarian, bladder, head & neck cancers etc
- Rising demand for targeted therapies: The rising demand for targeted therapies is another key growth driver for arsenic trioxide drugs market. Targeted therapies are those that attack specific molecules or cells that contribute to the development or progression of a disease, while leaving healthy cells unaffected thereby reducing adverse effects associated with traditional chemotherapy treatments . Arsenic trioxide belongs to a class of targeted therapy known as differentiation inhibitors which block cell division by interfering with an enzyme called protein kinase C-alpha (PKC-alpha). As such it has been shown to be more effective than traditional chemotherapies in treating APL patients
Scope Of The Report
Report Attributes
Report Details
Report Title
Arsenic Trioxide Drugs Market Research Report
By Type
1mg/ml, 2mg/ml
By Application
Hospital, Pharmacy
By Companies
Cephalon, Cephalon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Arsenic Trioxide Drugs Market Report Segments:
The global Arsenic Trioxide Drugs market is segmented on the basis of:
Types
1mg/ml, 2mg/ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cephalon
- Cephalon
Highlights of The Arsenic Trioxide Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1mg/ml
- 2mg/ml
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Arsenic Trioxide Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Arsenic trioxide drugs are medications that contain arsenic as one of their main ingredients. These medications are used to treat a variety of conditions, including cancer.
Some of the key players operating in the arsenic trioxide drugs market are Cephalon, Cephalon.
The arsenic trioxide drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Arsenic Trioxide Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Arsenic Trioxide Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Arsenic Trioxide Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Arsenic Trioxide Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Arsenic Trioxide Drugs Market Size & Forecast, 2020-2028
4.5.1 Arsenic Trioxide Drugs Market Size and Y-o-Y Growth
4.5.2 Arsenic Trioxide Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1mg/ml
5.2.2 2mg/ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Arsenic Trioxide Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Arsenic Trioxide Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1mg/ml
9.6.2 2mg/ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1mg/ml
10.6.2 2mg/ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1mg/ml
11.6.2 2mg/ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1mg/ml
12.6.2 2mg/ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1mg/ml
13.6.2 2mg/ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Arsenic Trioxide Drugs Market: Competitive Dashboard
14.2 Global Arsenic Trioxide Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cephalon
14.3.2 Cephalon
